Significance for public health
==============================

The aim of this research was to assess the association between polychlorinated biphenyls (PCBs) serum levels, glycaemia and diabetes, with a cross-sectional population-based study and a subsequent cohort study with a 7 year follow-up. An association between diabetes and concentration of PCBs serum levels was found by crude analysis, but it disappeared when adjusting for education, body mass index, age and gender as confounders.

The results of this study, which was carried on people living in a highly PCB-polluted area, provide information on the possible intervention of Public Health to contrast onset of diseases related to PCB exposure and put forward some useful suggestions for an environmental policy.

Introduction {#sec1-1}
============

Polychlorinated biphenyls (PCBs) are defined as persistent organic pollutants (POPs) and toxic chemicals, which persist in the environment for long periods of time and biomagnify as they move up through the food chain.[@ref1] PCBs are mixtures of up to 209 different compounds (congeners), depending on the number and position of chlorine atoms attached to the biphenyl molecule. PCBs were widely used in the past, especially in electrical, heat transfer and hydraulic equipment, and in plasticizers, paints, plastic and rubber products, but their production was stopped in many countries in response to the negative impact that these compounds had on environmental and human health.^[@ref1]^ PCBs, especially the 12 PCB congeners that have dioxin-like activity, have been linked to several and adverse health effects on human and animals, such as: cancer,^[@ref1]^ damage to the nervous system, reproductive disorders and disruption of the endocrine and immune systems.^[@ref2]^ Recently, it has been suggested that POPs stored in body fat may contribute to the onset of diabetes or insulin resistance, in addition to obesity, unhealthy diet and physical inactivity.^[@ref3]^ PCBs, especially PCB 153, and PCDD/Fs were found to be associated with diabetes in various studies carried out in the 2000s.^[@ref4]^ However, no clear pathogenic mechanism has been identified and the association of dioxins and PCBs with diabetes hasn't been found in other studies.^[@ref10]^ So, up to date, no conclusion can be drawn at present and more research is required.^[@ref3]^ In Brescia, a highly industrialised town in Northern Italy with about 200,000 inhabitants, a chemical factory produced PCBs from 1930 to 1984, and these compounds polluted the soil of nearby agricultural areas via irrigation channels, entered the food chain and thus accumulated in human beings.^[@ref15],[@ref16]^ Other POPs, including polychlorinated dibenzo-para-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs), have also been found in the environment, animal-derived food (meat, eggs, milk and dairy products) and human sera, with a high correlation with PCB levels.^[@ref17],[@ref18]^ The aim of this study was to assess the association between PCB serum levels and glycaemia and diabetes in people living in this town.

Design and methods {#sec1-2}
==================

Study population {#sec2-1}
----------------

In the first phase of this cross-sectional and cohort study (2003-2004), we performed a survey on a random sample of adult residents in Brescia (Italy). Here, there was an important factory which produced organochlorine compounds, including PCBs, from the 1930s to 1984. PCBs were released into drainage water, which was discharged in irrigation channels and then accumulated in the soil of a nearby agricultural area, entering the food chain. Therefore, PCB polluted food, mainly animal products (chicken, eggs, milk and cheese), was consumed by several individuals living in the town.^[@ref15],[@ref16]^ Four different areas and their residents were identified according to soil PCB concentrations. The stratified sampling design was based on separate frames for subjects resident in each of these 4 areas, separately for sex and divided into six age groups, from 20 to 79 years. An invitation letter was sent to 1200 subjects: 308 of them did not respond the letter and could not be found by telephone. Among the 892 contacted people, 579 (64.8%) agreed to participate and gave a blood sample for laboratory determination; 527 of them were face-to-face interviewed by a trained nurse using a structured questionnaire, including questions on demographic variables, weight and height, residential and occupational history, smoking habit, alcohol intake, and presence of past and current diseases.

Body mass index (BMI) was computed by dividing the weight in kilograms by the square of the height in meters. We indentified 3 categories of BMI according to the cut-off points proposed by the WHO:^[@ref19]^ normal weight (BMI\<25 kg/m^2^), overweight (25≤BMI\<30 kg/m^2^) and obese (BMI≤30 kg/m^2^).

Subjects were questioned about the presence of diabetes and current use of insulin or oral hypoglycaemic agents. They were considered to have diabetes (prevalent cases) if they reported a history of type I or type II diabetes and/or if they were currently using insulin or oral hypoglycaemic agents. In Italy, citizens are registered in the General Registry Health database of the National Health Service (NHS) with a unique identification code. All subjects affected by chronic diseases can benefit free of charge analyses, drugs, physicians' visits, and other services provided by the NHS. All these data are made available to each Local Health Authority. Therefore, in order to detect the occurrence of diabetes, we merged our database with Brescia Local Health Authority (LHA) health-care one, including both administrative and health data of all the subjects living in the area. A complete description and validity considerations on this database are given elsewhere.^[@ref20]^ In the second phase of the study, all subjects enrolled in the survey were included in a cohort study. During a 7-year follow-up, from 1^st^ January 2004 to 31^st^ December 2011, all the new cases of diabetes, which occurred in the cohort, were retrieved using the LHA database (incident cases).

The Ethics Committee of the LHA approved the project and each participant provided informed consent.

Blood sampling and storage {#sec2-2}
--------------------------

A 20-mL blood sample was collected from each subject. Fasting plasma glucose was determined using the glucose-oxidase method. Serum lipid profile, including total cholesterol and triglycerides, was evaluated using enzymatic methods.

The serum was separated by centrifugation at 3500 rpm (5 min) and stored at --20°C until the chemical analyses were performed.

Polychlorinated biphenyls analyses {#sec2-3}
----------------------------------

We determined the serum concentration of 24 PCB congeners - 28, 31, 52, 77, 81, 101, 105, 114, 118, 123, 126, 128, 138, 153, 156, 157, 167, 169, 170, 180, 189, 194, 206 and 209 - according to Ballschmiter and Zell's study.^[@ref21]^

PCBs were measured using a Hewlett-Packard 6890N gas chromatograph coupled with an MSD HP 5973. Analytical procedure, limit of quantification and method accuracy assessment are reported elsewhere.^[@ref15]^ PCB analysis was performed at the Laboratory of Occupational Hygiene and Toxicology, Brescia University, Italy.

For the 12 dioxin-like congeners (DL-PCBs) 77, 81, 126, 169, 105, 114, 118, 123, 156, 157, 167 and 189, the total toxic equivalency (TEQ) was computed using toxic equivalency factor (TEF) defined by Van den Berg's study.^[@ref22]^ A minimum concentration of half the quantification limit (0.05 ng/mL) was attributed to subjects with no detection for PCB congeners that were detectable in at least 30% of subjects. A null value was attributed to congeners with detectable values in less than 30% of subjects, according to common suggestions.^[@ref15]^ Total PCB concentration was calculated by summing up values of PCB congeners.

Since PCBs are transported in the lipidic fraction of the blood, their concentration depends on the amount of serum lipids. The ratio of PCB concentrations to total lipid levels was therefore computed (lipidadjusted PCB concentration) and expressed as ng/g lipid, the standard practice in studies investigating PCB serum levels. We calculated the total lipid concentration from cholesterol and triglyceride levels, using the formula suggested by Philips' work:^[@ref23]^ total serum lipids (g/dL) = 2.27 × serum cholesterol (g/dL) + triglycerides (g/dL) + 0.623.

Statistical analysis {#sec2-4}
--------------------

The distribution of total PCB serum levels was examined using common statistical techniques for exploratory analysis. Due to the asymmetrical, non-normal distribution of total PCBs and of each PCB congener, the mean, median, range and 95^th^ centile of the distributions are shown. PCB congeners were classified on the basis of their different functional groups, according to the classification proposed by various authors as:^[@ref24]^ i) congeners with immunotoxic activities (PCB 138, 153 and 180); ii) low-chlorinated PCBs with pseudo-oestrogen activity (PCB 28, 52 and 153); iii) high-chlorinated PCBs with anti-oestrogenic activities (PCB 170, 180 and 194); iv) PCBs that can induce phenobarbital (PCB 101, 153, 180 and 194). The proportions of subjects with diabetes (prevalent and incident cases separately and all together) were compared according to the total PCB distribution tertiles, specific PCB congeners and PCB functional groups and TEQ DL- PCBs. Logistic regression analysis was also performed to evaluate the association between diabetes, PCB serum levels (distribution tertiles), adjusting for education, age, gender and BMI, and the corresponding odds ratios (ORs) were computed. Glycaemia levels according to the total PCB distribution tertiles, PCB 153 and PCB functional groups were compared using the analysis of variance on log-transformed data. Multiple regression of log-glycaemia as the dependent variable was also performed, with PCBs levels, education, gender, age and BMI as independent variables. All the statistical tests were two-sided with a 0.05 P-value to refute the null hypothesis. Statistical analysis was performed using STATA software for personal computer (Stata Statistical Software release 10, 2003; Stata Corporation, College Station, Texas, USA).

Results {#sec1-3}
=======

A total of 527 subjects were enrolled. [Table 1](#table001){ref-type="table"} shows the distribution of participants according to education, age, gender and BMI: 48.5% of subjects were males, mean age was 50.6 years, mean BMI was 24.8 kg/m^2^, and 56% had less than 8 years of schooling. According to BMI categories, 291 subjects (55.2%) had normal weight, 163 (30.9%) were overweight and 73 (13.9%) were obese.

[Table 2](#table002){ref-type="table"} shows descriptive statistics of the lipid-adjusted serum levels of total PCBs, PCB congeners and PCB functional groups. The median serum concentration of total PCBs was 713.7 ng/g lipid and the range was 55.4-34377.8 ng/g lipid. PCB 153 and PCB 180 contributed most to total PCB level: the medians of PCB 153 and 180 were 207.9 (range 4.7-5618.1) ng/g lipid and 233.9 (range 9.1-11296.4) ng/g lipid, respectively. The PCB congeners set out in the table were over the detection limit in all subjects. No data are shown for congeners that were undetectable in all or almost all samples, *i.e.* PCB 28 (0% of detectable values), PCB 52 (0%), PCB 101 (1.5%) and PCB 126 (0%). We found no differences between males and females in serum levels of total and single PCB congeners. In the cross sectional study, 28 subjects were found to have diabetes (prevalence: 5.3%; 95% CI: 3.3-7.2). All the 527 subjects, who were already included in the cross-sectional study, were also enrolled in the cohort study. After 7 years of follow-up, 32 (6.0%) of them were dead and 9 (1.7%) were not found in the LHA database (lost at follow-up). Other 25 subjects of the cohort developed diabetes (incident cases) among those who did not have the disease at the enrolment (cumulative incidence: 5.0%; 95% CI: 3.1-6.9). Overall, 53 (10.0%) subjects were found to have diabetes according to the initial interview (n=28) or during the follow-up (n=25). For all the subjects, who reported diabetes at the interview, the presence of that disease was confirmed via the LHA database.

Prevalent and incident cases of diabetes were considered all together for the comparison with non-diabetics subjects (controls). The diabetes cases were older than controls, with a median age of 62.4 and 51.3 years, respectively (P\<0.001). PCBs concentration increased with the age in both diabetes cases and subjects without diabetes (P\<0.01): in the whole sample, PCB serum levels were higher in subjects aged 62.4 years and older (median: 1229.5 ng/g lipid) compared with younger subjects (median: 554.8 ng/g lipid) (P\<0.001).

The median serum levels of total PCBs, according to the BMI, were, with respect to normal weight subjects (628.8 ng/g lipid), higher in overweight subjects (867.2 ng/g lipid, P\<0.001), but not significantly different in obese subjects (684.6 ng/g lipid; P=0.1). Diabetes prevalence increased with age and BMI, with a maximum of 20.5% among subjects aged 60 years and over, and 29.4% among the 68 obese subjects (BMI of 30 and over), more than six times the proportion in normal-weight individuals (29.4% *vs* 4.1%). Only one (5%) of those obese subjects had total PCB levels higher than the median of the distribution. When comparing prevalent and incident diabetes cases, we found no differences in serum levels of total PCBs between them: mean serum levels of PCBs were 1360.7 and 1166.9 ng/g lipid in prevalent and incident cases, respectively (P=0.18).

The odds ratios for diabetes according to tertiles of serum total PCB concentration, adjusted for education, BMI, age and gender, were: for prevalence of diabetes: OR=0.5 (0.1-2.2) for both 2^nd^ and 3^rd^ *vs* 1^st^ tertiles; for cumulative incidence of diabetes: OR=2.3 (0.6-9.6) for 2^nd^ and 0.9 (0.2-5.0) for 3^rd^ *vs* 1^st^ tertiles, respectively. There was no association between diabetes and total PCBs, PCB 153, 4 PCB functional groups and TEQ DL-PCBs concentration both in prevalent cases and in incident cases. According to those findings, we decided to analyse the association between diabetes and PCBs concentration combining all diabetes cases together to increase the power of the study.

[Table 3](#table003){ref-type="table"} shows the overall cases of diabetes (prevalent and incident cases together) and the odds ratios (ORs) for diabetes according to distribution tertiles for the serum concentration of lipid-adjusted total PCBs, PCB 153, PCB functional groups and TEQ DL-PCBs. The proportion of diabetes cases increased with the concentration of total PCBs, single PCB congeners and PCB functional group. However, diabetes did not show a statistically significant association with PCB when adjusting for education, BMI, age and gender by logistic regression analysis. The differences between the crude and adjusted OR estimates were entirely due to age, which therefore was a confounder of the association whereas gender, BMI and education were not. Diabetes was associated with obesity (BMI≤30), but not overweight (24.9≤BMI≤30), the OR for obesity being 7.2 (3.4-16.2), and none of these associations was confounded or modified by PCB serum levels. No differences were found when restricting the analysis to the 25 incident diabetes cases only. No association was found between diabetes and serum concentration of lipid-adjusted PCBs according to concentration tertiles when analysing subjects with normal weight, overweight and obesity separately. No difference was found in the OR estimates for PCB tertiles when dichotomizing subjects in those under and over 62.4 years of age (median age of diabetics): the ORs for the 3^rd^ *vs* 1^st^ tertile were 0.8 (95% CI:0.2-3.8) and 0.3 (95% CI:0.1-1.5), respectively. A high dispersion of glycaemia according to PCB lipid-adjusted values was observed ([Figure 1](#fig001){ref-type="fig"}), with a weak linear correlation (Spearman's r=0.2). However, multiple regression analysis, with logarithm of glycaemia as the dependent variable, showed no association with log-transformed total PCB concentration when including age, BMI, education and gender. [Table 4](#table004){ref-type="table"} shows the geometric mean of glycaemia according to tertiles of lipid-adjusted total PCBs, PCB 153 and four functional groups in 474 subjects without diabetes. Statistically significant associations between logarithm of glycaemia and tertiles of PCB lipid-adjusted levels were found for total PCBs, PCB153 and four PCB functional groups using one-way ANOVA on log-transformed glycaemia data, which were not confirmed when adjusting for education, BMI, age and gender by multi-way ANOVA. The associations between PCB serum levels and diabetes and glycaemia were also analysed in men and women separately, providing similar results to those observed in total subjects.

Discussion
==========

In spite of a high exposure of the study population to PCBs and possibly PCDD/Fs for about half a century, we found no relationship between total PCB serum levels and diabetes. An association of diabetes with the concentration of lipid-adjusted total PCBs, PCB 153, PCB functional group and TEQ DL-PCB serum levels was found by crude analysis, but it disappeared when adjusting for age.

Accordingly, glycaemia increased with serum levels of total PCB, PCB 153, and immunotoxic, high-chlorinated and phenobarbital-inducing PCBs, but again no association was found when multiple regression analysis, including confounders, was performed. ANOVA models using PCB distribution tertiles confirmed these findings.

Several cross-sectional studies and cohort studies have evaluated the association between serum concentration of PCBs and diabetes, glycaemia or insulin resistance so far. Some of them have been conducted among people with high environmental exposure to PCBs or high intake of contaminated food,^[@ref27],[@ref28]^ but the majority of them included subjects with low serum concentrations of PCBs.^[@ref4],[@ref6],[@ref7],[@ref9],[@ref29]^ Many, ^[@ref4],[@ref6],[@ref27],[@ref28],[@ref30]^ but not all,^[@ref5],[@ref10],[@ref36]^ studies found a statistically significant association between PCB concentration and diabetes, glycaemia or insulin resistance. Two of them found a positive association among women, but not among men,^[@ref37],[@ref38]^ and one found a positive association for some PCB congeners but not sum of PCBs.^[@ref29]^ One study found PCB effects only at low doses, suggesting a non-traditional dose-response relationship of POPs with diabetes,^[@ref30],[@ref32]^ although opposite results (associations only at the highest levels of PCB contaminations and dose-effect relationship) were reported by many others.^[@ref6],[@ref8],[@ref27],[@ref29],[@ref34]^ These findings are substantially in agreement with those reported in a recent National Toxicology Program Workshop Review, although it did not include the studies published in 2011-12.^[@ref39]^ Overall, these discrepancies does not seem to depend on study area, study design, PCB serum levels, age and gender of investigated people, and may be due to differences in exposure, in terms of quantity and quality of PCBs investigated, and to not having taking account of confounding factors and interaction.

Various mechanisms to measure diabetogenic effect of dioxin and PCB have been suggested.^[@ref3],[@ref40],[@ref41]^ These chemicals exert their effects by binding to the aryl-hydrocarbon receptor, which could promote diabetogenesis by antagonism of peroxisome proliferation-activated receptors.^[@ref41]^ Some authors, however, suggest that the effect of POPs may be due to an interaction with the classic risk factors for diabetes, more than to a direct causal relationship. Indeed, the NHANES survey conducted on the U.S. general population found that obese people had a higher frequency of insulin resistance than normal weight individuals, but that the association between obesity and insulin resistance was present only in people with high POP levels.^[@ref8],[@ref42]^ Other authors have suggested that PCB may act through increased inflammatory responses or like steroid hormones,^[@ref43]^ which may play a role in the development of diabetes.^[@ref44]^ However, an independent substantial role of POPs in causing diabetes at the commonly found environmental levels seems questionable to us, as the present worldwide diabetes epidemic has been related universally to an increase in obesity, high calorie and high glycaemic load diets and physical inactivity, and various trials have clearly shown that changes in diet and exercise can prevent diabetes effectively, although they obviously cannot remove POPs from the body, as noted by others.^[@ref3]^

Serious environmental contamination of a PCB mixture was found in the Brescia area, with a prevalence of hexa/hepta-chlorinated congeners and a minor component of lower chlorinated congeners and dioxin-like congeners. PCDDs and PCDFs, but not TCDD, were also found, although the DL-PCBs contributed to the overall toxicity equivalent (TEQ) substantially, sometimes outweighing the contribution of PCDD/Fs.^[@ref17],[@ref18]^

This study has various strengths. First, it is a population-based study, aiming to investigate PCB serum levels and the possible effects of this exposure in a random sample of the general adult population living in the town. Second, all the people included in the study were living in an industrialised town that has been highly polluted by PCBs, PCDDs and PCDFs for many years. The high levels of PCBs still found in the soil in some areas of the town (up to 8 mg/kg) suggest a persistent exposure to PCBs for the whole population, long enough to allow an effect on glycaemia metabolism or diabetes to be detected. In fact, we found that some of the people studied had very high serum PCB levels, with total PCB lipid-adjusted values ranging up to 34377.8 ng/g lipid, 13 times higher than the reference value for the adult population living in highly industrialized areas in Italy (2650 ng/g lipid) and similar to those found in other PCB-polluted areas,^[@ref45]^ such as Anniston (USA) and Michalovce (Slovakia).^[@ref27],[@ref28]^ We also examined 24 PCB congeners, including the most commonly implicated as endocrine disruptors, and we collected information on serum lipid values and body mass index in order to check for possible confounders.

Furthermore, the presence of diabetes was confirmed in all cases using the LHA database, including clinical data of high validity for each subject.

This study has some limitations as well. First of all, the relatively small number of subjects with diabetes, which is not unexpected since a random sample of the general adult population was included in the study, most of whom were healthy. In our samples the diabetes percentage was 12.9% in males and 7.3% in females, in agreement with national data (10% in males and 7% in females).^[@ref46]^

In conclusion, this cross-sectional and cohort study in a highly PCB-polluted area does not support the hypothesis that environmental exposure to PCBs and other POPs is associated with diabetes or glycaemia.

we are grateful to the nurses who performed the interviews and to the Local Health Authority technical personnel who collaborated in the study. The Ethics Committee of the Brescia Local Health Authority approved the project.
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###### 

Age, gender, body mass index and education of subjects enrolled in the study.

  ------------------------------------------------------------------------
                            Males N. (%)   Females N. (%)   Total N. (%)
  ------------------------- -------------- ---------------- --------------
  All subjects              256 (48.5)     271 (51.5)       527 (100)

  Age (years)                                               

  20-39                     72 (28.2)      81 (29.9)        153 (29.0)

  40-59                     89 (34.7)      105 (38.7)       194 (36.8)

  60-79                     95 (37.1)      85 (31.4)        180 (34.2)

  Mean ± SD age (years)     51.7±16.4      50.3±16.0        50.6±6.2

  Mean ± SD BMI (kg/m^2^)   25.3±3.8       24.3±5.0         24.8±4.5

  Education (years)\        59 (23.0)      79 (29.2)        138 (26.2)
  ≤5                                                        

  6-8                       70 (27.4)      79 (29.2)        149 (28.3)

  \>8                       127 (49.6)     113 (41.6)       240 (45.5)
  ------------------------------------------------------------------------

SD, standard deviation; BMI, body mass index.

###### 

Lipid-adjusted polychlorinated biphenyls (PCB) congener, total PCB, PCB functional group and total toxic equivalency dioxin like PCBs serum levels (ng/g lipid).

  PCB congener (ng/g lipid)                                 Mean     Median   95^th^ percentile   Range
  --------------------------------------------------------- -------- -------- ------------------- --------------
  Total PCBs                                                1309.3   713.7    3520.9              55.4-34377.8
  138                                                       187.5    118.2    481.9               4.7-4192.9
  153                                                       331.6    207.9    883.3               4.7-5618.1
  170                                                       113.0    64.4     332.3               5.6-2737.6
  180                                                       423.7    233.9    1032.5              9.1-11296.4
  194                                                       114.2    41.0     352.4               4.1-4216.3
  Immunotoxic PCBs (PCB138+153+180)                         942.9    565.7    2459.9              37.4-18732.4
  Pseudo-oestrogen PCBs (PCB28+52+153)                      331.6    207.9    883.3               4.7-5618.1
  High chlorinated anti-oestrogenic PCBs (PCB170+180+194)   651.0    342.4    1668.5              27.4-18122.5
  Phenobarbital inducer PCBs (PCB101+153 +180+194)          869.8    499.9    2233.8              37.4-20402.1
  TEQ DL-PCBs                                               0.13     0.05     0.43                0.03-4.3

PBC, polychlorinated biphenyls congener; TEQ, total toxic equivalency.

###### 

Association between diabetes and tertiles of serum concentration of lipid-adjusted total polychlorinated biphenyls (PCBs), PCB 153, four PCB functional groups and total toxic equivalency dioxin like PCBs.

  Lipid-adjusted PCB concentration (ng/g lipid)             Presence of diabetes No. of subjects/total   Prevalence (95% CI)   Crude odds ratio (95% CI)   Adjusted odds ratio[\*](#tfn001){ref-type="table-fn"} (95% CI)
  --------------------------------------------------------- -------------------------------------------- --------------------- --------------------------- ----------------------------------------------------------------
  Total                                                     53/527                                       10.0 (7.4-12.5)                                   
  Total PCBs                                                                                                                                               
  ≤433.7                                                    8/173                                        4.6 (1.4-7.7)         1                           1
  433.7-996.7                                               22/174                                       12.6 (7.6-17.5)       2.9 (1.3-6.9)               1.1 (0.4-3.0)
  \>996.7                                                   23/180                                       12.8 (7.9-17.6)       3.0 (1.3-6.9)               0.7 (0.2-2.0)
  PCB 153                                                                                                                                                  
  ≤135.8                                                    8/173                                        4.6 (1.4-7.7)         1                           1
  135.8-282.0                                               19/174                                       10.9 (6.2-15.5)       2.5 (1.0-5.9)               1.1 (0.4-2.8)
  \>282.0                                                   26/180                                       14.4 (9.2-19.5)       3.4 (1.5-7.9)               0.9 (0.3-2.4)
  Immunotoxic PCBs (PCB138+153+180)                                                                                                                        
  ≤374.4                                                    8/172                                        4.6 (1.4-7.7)         1                           1
  374.4-752.2                                               21/175                                       12.0 (7.1-16.8)       2.8 (1.2-6.5)               0.9 (0.3-2.6)
  \>752.2                                                   24/180                                       13.3 (8.3-18.2)       3.1 (1.3-7.2)               0.7 (0.2-2.1)
  Pseudo-oestrogen PCBs (PCB28+ 52+ 153)                                                                                                                   
  ≤135.8                                                    8/173                                        4.6 (1.4-7.7)         1                           1
  135.8-282.0                                               19/174                                       10.9 (6.2-15.5)       2.5 (1.0-5.9)               1.0 (0.4-2.8)
  \>282.0                                                   26/180                                       14.4 (9.2-19.5)       3.4 (1.5-7.9)               0.9 (0.3-2.4)
  High chlorinated anti-oestrogenic PCBs (PCB170+180+194)                                                                                                  
  ≤203.4                                                    9/173                                        5.2 (1.8-8.5)         1                           1
  2.03.4-488.9                                              24/174                                       13.8 (8.6-18.9)       2.9 (1.3-6.4)               1.0 (0.4-2.8)
  \>488.9                                                   20/180                                       11.1 (6.5-15.6)       2.2 (1.0-5.1)               0.6 (0.2-1.8)
  Phenobarbital inducer PCBs (PCB101+153+180+194)                                                                                                          
  ≤309.2                                                    8/173                                        4.6 (1.4-7.7)         1                           1
  309.2-669.9                                               22/174                                       12.6 (7.6-17.5)       2.9 (1.3-6.9)               1.0 (0.4-2.7)
  \>669.9                                                   23/180                                       12.8 (7.9-17.6)       3.0 (1.3-6.9)               0.7 (0.2-2.2)
  TEQ DL-PCBs                                                                                                                                              
  ≤0.03                                                     12/228                                       5.2 (2.3-8.0)         1                           1
  0.03-0.09                                                 15/98                                        15.3 (8.0-22.4)       3.2 (1.4-7.2)               1.2 (0.5-3.2)
  \>0.09                                                    26/201                                       12.9 (8.2-17.5)       2.6 (1.3-5.4)               0.8 (0.3-1.9)

\*Logistic regression models included age, gender, education and body mass index. CI, confidence interval; PBC, polychlorinated biphenyls; TEQ, total toxic equivalency.

###### 

Geometric mean of glycaemia according to tertiles of lipid-adjusted polychlorinated biphenyls in 474 subjects without diabetes.

  Tertiles of lipid-adjusted PCB concentration (ng/g lipid)   Geometric mean of glycaemia   One-way ANOVA on log-transformed data P values   Multi-way ANOVA[\*](#tfn002){ref-type="table-fn"} on log-transformed data P values
  ----------------------------------------------------------- ----------------------------- ------------------------------------------------ ------------------------------------------------------------------------------------
  Total                                                       86.7                                                                           
  Total PCBs                                                                                                                                 
  ≤433.7                                                      84.2                          0.0009                                           0.17
  433.7-996.7                                                 88.8                                                                           
  \>996.7                                                     88.0                                                                           
  PCB 153                                                                                                                                    
  ≤135.8                                                      84.3                          0.001                                            0.75
  135.8-282.0                                                 88.0                                                                           
  \>282.0                                                     88.8                                                                           
  Immunotoxic PCBs (PCB138+153+180)                                                                                                          
  ≤374.4                                                      84.3                          0.001                                            0.80
  374.4-752.2                                                 87.9                                                                           
  \>752.2                                                     88.8                                                                           
  Pseudo-oestrogen PCBs (PCB28+52+153)                                                                                                       
  ≤135.8                                                      84.3                          0.001                                            0.75
  135.8-282.0                                                 88.0                                                                           
  \>282.0                                                     88.8                                                                           
  High chlorinated anti-oestrogenic PCBs (PCB170+180+194)                                                                                    
  \>203.4                                                     84.2                          0.009                                            0.18
  2.03.4-488.9                                                88.9                                                                           
  \>488.9                                                     87.2                                                                           
  Phenobarbital inducer PCBs (PCB101+153+180+194)                                                                                            
  ≤309.2                                                      84.5                          0.004                                            0.43
  309.2-669.9                                                 88.2                                                                           
  \>669.9                                                     88.3                                                                           
  TEQ DL-PCB                                                                                                                                 
  ≤0.03                                                       85.1                          0.01                                             0.14
  0.03-0.09                                                   86.8                                                                           
  \>0.09                                                      89.3                                                                           

\*Fitted model included age, gender, education and body mass index. PBC, polychlorinated biphenyls; TEQ, total toxic equivalency
